207 related articles for article (PubMed ID: 34036514)
1. Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
Penitenti F; Landoni L; Scardoni M; Piredda ML; Cingarlini S; Scarpa A; D'Onofrio M; Girelli D; Davi MV
Endocrine; 2021 Oct; 74(1):180-187. PubMed ID: 34036514
[TBL] [Abstract][Full Text] [Related]
2. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
Krauss T; Ferrara AM; Links TP; Wellner U; Bancos I; Kvachenyuk A; Villar Gómez de Las Heras K; Yukina MY; Petrov R; Bullivant G; von Duecker L; Jadhav S; Ploeckinger U; Welin S; Schalin-Jäntti C; Gimm O; Pfeifer M; Ngeow J; Hasse-Lazar K; Sansó G; Qi X; Ugurlu MU; Diaz RE; Wohllk N; Peczkowska M; Aberle J; Lourenço DM; Pereira MAA; Fragoso MCBV; Hoff AO; Almeida MQ; Violante AHD; Quidute ARP; Zhang Z; Recasens M; Díaz LR; Kunavisarut T; Wannachalee T; Sirinvaravong S; Jonasch E; Grozinsky-Glasberg S; Fraenkel M; Beltsevich D; Egorov VI; Bausch D; Schott M; Tiling N; Pennelli G; Zschiedrich S; Därr R; Ruf J; Denecke T; Link KH; Zovato S; von Dobschuetz E; Yaremchuk S; Amthauer H; Makay Ö; Patocs A; Walz MK; Huber TB; Seufert J; Hellman P; Kim RH; Kuchinskaya E; Schiavi F; Malinoc A; Reisch N; Jarzab B; Barontini M; Januszewicz A; Shah N; Young WF; Opocher G; Eng C; Neumann HPH; Bausch B
Endocr Relat Cancer; 2018 Sep; 25(9):783-793. PubMed ID: 29748190
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Speisky D; Duces A; Bièche I; Rebours V; Hammel P; Sauvanet A; Richard S; Bedossa P; Vidaud M; Murat A; Niccoli P; Scoazec JY; Ruszniewski P; Couvelard A;
Clin Cancer Res; 2012 May; 18(10):2838-49. PubMed ID: 22461457
[TBL] [Abstract][Full Text] [Related]
4. Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease.
Tirosh A; Sadowski SM; Linehan WM; Libutti SK; Patel D; Nilubol N; Kebebew E
JAMA Oncol; 2018 Jan; 4(1):124-126. PubMed ID: 29075773
[TBL] [Abstract][Full Text] [Related]
5. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
7. Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features.
Corcos O; Couvelard A; Giraud S; Vullierme MP; Dermot O'Toole ; Rebours V; Stievenart JL; Penfornis A; Niccoli-Sire P; Baudin E; Sauvanet A; Levy P; Ruszniewski P; Richard S; Hammel P
Pancreas; 2008 Jul; 37(1):85-93. PubMed ID: 18580449
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic neuroendocrine tumors in French VHL mutation carriers: a multicentric retrospective study.
Muller M; Hammel P; Couvelard A; Védie AL; Cros J; Burnichon N; Hercent A; Sauvanet A; Richard S; de Mestier L
J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38706378
[TBL] [Abstract][Full Text] [Related]
9. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
[TBL] [Abstract][Full Text] [Related]
11. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease.
Libutti SK; Choyke PL; Alexander HR; Glenn G; Bartlett DL; Zbar B; Lubensky I; McKee SA; Maher ER; Linehan WM; Walther MM
Surgery; 2000 Dec; 128(6):1022-7;discussion 1027-8. PubMed ID: 11114638
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation in von Hippel-Lindau disease.
Reich M; Jaegle S; Neumann-Haefelin E; Klingler JH; Evers C; Daniel M; Bucher F; Ludwig F; Nuessle S; Kopp J; Boehringer D; Reinhard T; Lagrèze WA; Lange C; Agostini H; Lang SJ
Acta Ophthalmol; 2021 Dec; 99(8):e1492-e1500. PubMed ID: 33720516
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation of Von Hippel Lindau syndrome type 2B associated with VHL p.A149S mutation in a large Turkish family.
Mete T; Berker D; Yilmaz E; Ozgen G; Yalcin Y; Tuna M; Ciliz D; Onen M; Aydin Y; Guler S
Endocrine; 2014 Feb; 45(1):128-35. PubMed ID: 23673869
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
[TBL] [Abstract][Full Text] [Related]
17. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
[TBL] [Abstract][Full Text] [Related]
18. Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center.
Delman KA; Shapiro SE; Jonasch EW; Lee JE; Curley SA; Evans DB; Perrier ND
World J Surg; 2006 May; 30(5):665-9. PubMed ID: 16617420
[TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.
Vikkath N; Valiyaveedan S; Nampoothiri S; Radhakrishnan N; Pillai GS; Nair V; Pooleri GK; Mathew G; Menon KN; Ariyannur PS; Pillai AB
Fam Cancer; 2015 Dec; 14(4):585-94. PubMed ID: 25952756
[TBL] [Abstract][Full Text] [Related]
20. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
